SCHEMBL8998816

SCHEMBL8998816

CCCCCC(C)=CCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
CYP3A4 P08684 2/20 0.50
ALOX15 P16050 2/20 0.50
PTPN1 P18031 1/20 0.48
ALDH1A1 P00352 3/20 0.48
MAPT P10636 2/20 0.48
UGT1A1 P22309 1/20 0.48
SQLE Q14534 3/20 0.42
CES2 O00748 4/20 0.40
CES1 P23141 4/20 0.40
LSS P48449 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
AKR1B1 P15121 1/20 0.39
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 1/20 0.38
SLC22A6 Q4U2R8 1/20 0.37
SLC22A8 Q8TCC7 1/20 0.37
GPR84 Q9NQS5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8998810 1.00 MEN1 (0.50) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL10048632 1.00 MEN1 (0.50) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL8998668 0.98 MEN1 (0.48) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL5439961 0.98 MEN1 (0.48) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL8998659 0.98 MEN1 (0.48) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL8998739 0.98 MEN1 (0.48) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL8998633 0.98 MEN1 (0.48) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL4586773 0.98 MEN1 (0.48) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL22556624 0.98 MEN1 (0.48) MEN1KMT2ACYP3A4ALOX15PTPN1
SCHEMBL8998641 0.98 MEN1 (0.48) MEN1KMT2ACYP3A4ALOX15PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006699-A1 CELLS AND METHOD FOR PRODUCING ISOPRENOID MOLECULES WITH CANONICAL AND NON-CANONICAL STRUCTURES Københavns Universitet (DK) 2023-02-02 WO disclosed
EP-2966054-B1 METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE TAKASAGO PERFUMERY CO LTD (JP) 2019-01-02 EP disclosed
US-10029969-B2 Method of producing optically-active aldehyde TAKASAGO INTERNATIONAL CORPORATION (JP) 2018-07-24 US disclosed
EP-2966054-A1 METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE Takasago International Corporation (JP) 2016-01-13 EP disclosed
US-20150376102-A1 METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-12-31 US disclosed
EP-0258967-B2 Process for producing optically active alcohols TAKASAGO PERFUMERY CO LTD (JP) 1996-08-21 EP disclosed
US-4962242-A HYDROGENATING OLEFINIC ALCOHOL USING AS CATALYST A RUTHENIUM-OPTICALLY ACTIVE PHOSPHINE COMPLEX TAKASAGO PERFUMERY CO., LTD. (JP) 1990-10-09 US disclosed
EP-0258967-A2 Process for producing optically active alcohols Takasago Perfumery Co., Ltd. (JP) 1988-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10029969-B2 Method of producing optically-active aldehyde ALDH3A1, ALDH1A2, ADH1A MEN1 3945/4885KMT2A 3097/4885CYP3A4 194/4885
US-20150376102-A1 METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE ALDH3A1, ALDH1A2, ADH1A MEN1 3945/4885KMT2A 3097/4885CYP3A4 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.